Curriculum Vitae
`Richard N. Dalby
`
`UPersonal Information
`
`Qualifications
`
`Office Address
`
`
`
`
`
`0BUEducational Summary
`
`Sept. 1984 to Oct. 1988
`
`Ph.D. (University of Kentucky), M.R. Pharm. S. (Registered Pharmacist
`in UK, License # 78009), B. Pharm. (University of Nottingham).
`
`University of Maryland, Department of Pharmaceutical Sciences,
`20 North Pine Street, Baltimore, Maryland 21201.
`
`Telephone (410) 706-3245
`
`HUrdalby@rx.umaryland.eduU
`
`Fax (410) 706-0346
`
`University of Kentucky College of Pharmacy. Ph.D. in Pharmaceutical
`Sciences supervised by Dr. Peter R. Byron.
`
`Sept. 1980 to June 1983
`
`Nottingham University School of Pharmacy, B. Pharm. (Honors).
`
`1BUEmployment Summary
`
`Jan 2010 to present
`
`Jan. 2009 to Dec 2009
`
`July 2003 to present
`
`Sept. 1992 to present
`
`May 1997 to July 2003
`
`Aug. 2001 to Jan. 2002
`
`May 1997 to Sept. 1999
`
`Dec. 1989 to Aug. 1992
`
`Oct. 1988 to Nov. 1989
`
`Oct. 1984 to Sept. 1988
`
`Sept. 1983 to Sept. 1984
`
`Jun. to Sept. 1981 & 1982
`
`Associate Dean for Academic Affairs, School of Pharmacy, University of
`Maryland. Subsumed responsibilities of Associate Dean for Curricular
`and Instructional Resources in January 2012.
`
`Graduate Program Director, Department of Pharmaceutical Sciences,
`University of Maryland.
`
`Professor, Department of Pharmaceutical Sciences, University of
`Maryland (July 1996 to June 2003, Associate Professor; Sept. 1992 to
`June 1996, Assistant Professor).
`
`Affiliate Professor, School of Pharmacy, Medical College of Virginia /
`Virginia Commonwealth University (July 1996 to June 2003, Affiliate
`Associate Professor; Sept. 1992 to June 1996, Affiliate Assistant
`Professor).
`
`Vice Chair, Department of Pharmaceutical Sciences, University of
`Maryland.
`
`Acting Chair, Department of Pharmaceutical Sciences, University of
`Maryland.
`
`Graduate Program Director, Department of Pharmaceutical Sciences,
`University of Maryland.
`
`Research Assistant Professor at Medical College of Virginia / Virginia
`Commonwealth University, Department
`of
`Pharmacy
`and
`Pharmaceutics.
`
`Development Scientist, Fisons Pharmaceuticals (now sanofi aventis).
`Responsible for development of MDIs & DPIs. Offered promotion to
`Section Leader in 1989.
`
`Teaching and research assistant at the University of Kentucky College of
`Pharmacy.
`
`at Roche
`training
`pre-registration
`industry
`Pharmaceutical
`Pharmaceuticals and hospital pre-registration training at University
`College Hospital.
`
`Preregistration Pharmacy Student with the Boots Company (Community
`pharmacy).
`
`Page 1 of 24
`
`3M COMPANY 2012
`Mylan Phramaceuticals Inc. v. 3M Company
`IPR2015-02002
`
`

`
`Richard Dalby, Ph.D.
`
`
`
`UMembership of Professional Organizations
`
`
`
`the American Association of Pharmaceutical Scientists and member of
`Fellow of
`Pharmaceutical Society of Great Britain.
`
`the Royal
`
`2BUResearch Interests
`
`Formulation and evaluation of pressurized metered dose inhaler, dry powder, nebulizer, and nasal spray
`products. Development and evaluation of existing and proposed test methods for inhalation products.
`Laboratory testing and patient evaluation of novel pulmonary and nasal delivery devices. Design of
`patient
`education
`aids. More
`details
`at:
`HUwww.pharmacy.umaryland.edu/faculty/rdalby/ U
`or
`http://www.experts.scival.com/maryland/expert.asp?n=Dalby%2C+Richard+N%2E&u_id=1797.
`
`
`
`UPapers
`1.
`
`2.
`
`3.
`
`4.
`
`5.
`
`6.
`
`7.
`
`8.
`
`9.
`
`10.
`
`11.
`
`
`
`Automated Actuation of Nasal Spray Products: Effect of Hand Related Variability on the In Vitro
`Performance of Flonase® Nasal Spray; Diane V. Doughty, Wenchi Hsu and Richard N. Dalby.
`Drug Development and Industrial Pharmacy, Vol. 40, No. 6, Pages 711-718, June 2014.
`DOI:10.3109/03639045.2013.777735.
`Methodology for the In Vitro Evaluation of the Delivery Efficiency from Valved Holding Chambers
`with Facemasks; Zhen Xu, Wenchi Hsu, Dirk von Hollen, Ashwin Viswanath, Kurt Nikander and
`Richard Dalby Journal of Aerosols in Medicine and Pulmonary Drug Delivery, Volume 27,
`Supplement 1, S44-54, 2013. DOI: 10.1089/jamp.2013.1074. PMID: 24219816.
`Development of Respimat and its Clinical Utility in Respiratory Disorders, R N Dalby, J Eicher and
`B Zierenberg, Medical Devices: Evidence and Research. Medical Devices: Vol 1, No 4, pages
`145–155, 2011.
`Effect of Various Formulation and Administration Related Factors on Deposition Pattern of Nasal
`Spray Pumps. Vipra Kundoor and Richard N. Dalby. Pharmaceutical Research, Volume 28,
`Number 8, 1895-1904, 2011. PMID: 21499839.
`Automated Actuation of Nasal Spray Products: Determination and Comparison of Adult and
`Pediatric Settings. D. V. Doughty, C. Vibbert, M. E. Bollinger, A. Kewalramani and R. N. Dalby.
`Drug Development and Industrial Pharmacy. Vol. 37, No. 3, pages 359-366, 2010.
`Thousand Years of Pharmaceutical Aerosol’s Conference Paper. Deposition, imaging and
`clearance: What remains to be done? Aerosol Medicine and Pulmonary Drug Delivery, Volume
`23, Suppl 2, pages 1-19, 2010.
`Assessment of Facial and Ocular Deposition of Nebulized Aerosol Using a Color Based Method.
`Vipra Kundoor and Richard N. Dalby. Drug Development and Industrial Pharmacy, Pages 1-5,
`June 2010. PMID: 20545511.
`Demonstrating Bioequivalence of Locally Acting Orally Inhaled Drug Products (OIPs): Workshop
`Summary Report, Cosponsored by Product Quality Research Institute (PQRI) and Inhalation and
`Nasal Technology Focus Group (INTFG). Wallace P. Adams, Richard C. Ahrens, Mei-Ling Chen,
`David Christopher, Badrul A. Chowdhury, Dale P. Conner, Richard Dalby, Kevin Fitzgerald, Leslie
`Hendeles, Anthony J. Hickey, Günther Hochhaus, Beth L. Laube, Paul Lucas, Sau L. Lee,
`Svetlana Lyapustina, Bing Li, Dennis O’Connor, Neil Parikh, David A. Parkins, Prasad Peri, Gary
`R. Pitcairn, Michael Riebe, Partha Roy, Tushar Shah, Gur Jai Pal Singh, Sandra Suarez Sharp,
`Julie D. Suman, Marjolein Weda, Janet Woodcock and Lawrence Yu. J. Aerosol Medicine and
`Pulmonary Drug Delivery. Volume 23, Number 1, pp. 1–29, 2010.
`Assessment of Nasal Spray Deposition Pattern In A Silicone Human Nose Model Using A Color
`Based Method. Vipra Kundoor and Richard Dalby. Pharmaceutical Research, Volume 27,
`Number 1, Pages 30-36. January, 2010. DOI: 10.1007/s11095-009-0002-4.
`HUEffect of Flexible Dip-tubes and Shaking on Spray Weight Consistency in Nasal Sprays UH. Diane
`Doughty, Lei Li and Richard N. Dalby. J. Aerosol Medicine and Pulmonary Drug Delivery, Volume
`23, Number 2, pages 69-75, 2010.
`HUPhospholipid Induced In Vivo Particle Migration to Enhance Pulmonary Deposition UH. Sudipta
`Ganguly, Vikas Moolchandani, Natalie Eddington, Joseph Roche, Paul S. Shapiro, Shailaja
`Somaraju and Richard N. Dalby. J. Aerosol Medicine and Pulmonary Drug Delivery, Vol. 21, No.
`4: 343-350, Dec 2008.
`
`Page 2 of 24
`
`

`
`Richard Dalby, Ph.D.
`
`
`
`
`
`12.
`
`13.
`
`14.
`
`15.
`
`16.
`
`17.
`
`18.
`
`19.
`
`20.
`
`21.
`
`22.
`
`23.
`
`24.
`
`25.
`
`26.
`
`27.
`
`28.
`
`29.
`
`30.
`
`31.
`
`
`
`HUPhase I Clinical Trial of Repeat Dose Terameprocol Vaginal Ointment in Healthy Female
`Volunteers UH. Niharika Khanna, Richard Dalby, Alyson Connor, Ann Church, Jennifer Stern and
`Neil Frazer. Sexually Transmitted Diseases. 35(6):577-582, 2008.
`HUPhase I/II Clinical Safety Studies of Terameprocol Vaginal Ointment UH. Niharika Khanna, Richard
`Dalby, Ming Tan, Stephanie Arnold, Jennifer Sternand & Neil Frazer. Gynecologic Oncology,
`Volume 107, Issue 3, 554-562, 2007.
`The Analysis and Prediction of Functional Robustness of Inhaler Devices. Pallavi Nithyanandan,
`Stephen W. Hoag and Richard N. Dalby. Journal of Aerosol Medicine, 20 (1), 19-37, 2007.
`Validity of In Vitro Tests on Aqueous Spray Pumps as Surrogates for Nasal Deposition,
`Absorption and Biologic Response. Julie D. Suman, Beth L. Laube and Richard Dalby, J. Aerosol
`Medicine, 19 (4), 510-521, 2006.
`Positive Expiratory Pressure Changes Aerosol Distribution in Patients with Cystic Fibrosis. Beth
`L. Laube, David E. Geller, Ta-Chun Lin, Richard N. Dalby, Marie Diener-West and Pamela L.
`Zeitlin. Respiratory Care, 50 (11), 1438-1444, November 2005.
`HUThe Effect of Formulation Variables and Breathing Patterns on the Site of Nasal Deposition in an
`Anatomically Correct ModelUH. Yang Guo, Beth Laube and Richard Dalby. Pharmaceutical
`Research 22 (11), 1871-1878, November 2005.
`Who Nose, Richard Dalby, Yang Guo and Julie Suman. European Pharmaceutical Review, 10
`(1), 96-100, 2005.
`HUA Review of the Development of Respimat® Soft Mist Inhaler UH. Dalby, R, Spallek, M and Voshaar,
`T. International Journal of Pharmaceutics, Volume 283, Issues 1-2 , 1-9, 2004.
`Drug Delivery to the Nasal Cavity: In Vitro And In Vivo Assessment. Stephen P. Newman, Gary R
`Pitcairn and Richard N. Dalby. Critical Reviews in Therapeutic Drug Carrier Systems, 21 (1), 21-
`66, 2004.
`HUInhalation Therapy: Technical Milestones in Asthma TreatmentUH, Richard Dalby and Julie Suman.
`Advanced Drug Delivery Reviews, 55 (7), 779-791, 2003.
`Pulmonary Drug Delivery - What’s Next, Richard Dalby. European Pharmaceutical Review, 2,
`70-73, June 2003
`Allergen Challenge and Deposition of Nedocromil Sodium in Asthma, B.L. Laube, T. Lin, A.
`Valleteau, R.N. Dalby, F.B. Diemer and A.G. Togias. Journal of Aerosol Medicine, 15(4), 415-
`426, 2002.
`Predicting the Quality of Powders for Inhalation from Surface Energy, David P. Cline and Richard
`N. Dalby. Pharmaceutical Research, 9 (19), September 2002.
`HUNovel system to investigate the Effects Of Inhaled Volume And Rates Of Rise In Simulated
`Inspiratory Air Flow On Fine Particle Output From A Dry Powder Inhaler (DPI). UH Varsha Chavan
`and Richard Dalby. AAPS PharmSci; 4 (2) article 6 (2002).
`Relevance of In Vitro Tests of Nasal Solutions to Predict In Vivo Deposition., J.D. Suman, B.L.
`Laube, T. Lin, G. Brouet, and R. Dalby. Pharmaceutical Research, 19 (1) : 1-6 (2002).
`HUTargeting Aerosol Deposition In Patients With Cystic Fibrosis: Effects Of Alterations In Particle
`Size And Inspiratory Flow Rate UH, Beth L. Laube, Rajkumari Jashnani, Richard N. Dalby and
`Pamela Zeitlin. Chest ;118:1069 -1076 (2000).
`HUEffect Of Rise In Simulated Inspiratory Flow Rate And Carrier Particle Size On Powder Emptying
`From Dry Powder Inhalers UH, Varsha Chavan and Richard Dalby, American Association Of
`Pharmaceutical Scientists, AAPS PharmSci; 2 (2) article 10 (2000).
`Inhaled ATP Causes Mucin Release From Goblet Cell Of Intact Rat, Chan Young Shim, K. Chul
`Kim, Mi-Jeong Jo, Kyu Hwan Park, Richard Dalby and Kwang Ho Ko. Journal of Experimental
`Lung Research, 26: 1-11 (2000).
`Nasal Nebulizers Versus Nasal Spray Pumps: An Investigation Of Deposition And Mucociliary
`Clearance. Julie Suman, Beth L. Laube and Richard N. Dalby. Pharmaceutical Research, 16 (10):
`1648-1652 (1999).
`The Efficacy Of Slow Vs. Faster Inhalation Of Cromolyn Sodium In Protecting Against Allergen
`Challenge In Patients With Asthma, Beth L. Laube, Alan M. Edwards, Richard N. Dalby, Peter
`Creticos and Philip Norman. J. Allergy and Clinical Immunology, 101 (4) Part 1, 475-483 (1998).
`
`Page 3 of 24
`
`

`
`Richard Dalby, Ph.D.
`
`
`
`
`
`32.
`
`33.
`
`34.
`
`35.
`
`36.
`
`37.
`
`38.
`
`39.
`
`40.
`
`41.
`
`42.
`
`43.
`
`44.
`
`45.
`
`46.
`
`47.
`
`48.
`
`49.
`
`50.
`
`
`
`Evaluation Of Aerosol Drug Output From The Optichamber Spacer : Comparison To The
`Aerochamber In A Model System, Richard N. Dalby, Shailaja Somaraju, Varsha Chavan and
`Dayna Jarvis. Journal of Asthma, 35(2), 173-177 (1998).
`Predicting In Vivo Lung Deposition Of Cromolyn Sodium From In Vitro Estimates, Beth L. Laube,
`Rajkumari Jashnani and Richard N. Dalby. J. Aerosol Medicine, 11 (Supplement 1), 35-42 (1998).
`Also presented at the international Society for Aerosols in Medicine Focus Symposium, Towards
`meaningful laboratory tests for evaluation of pharmaceutical aerosols, San Juan, PR, January,
`1997.
`Liquefied Propellant Density - Measurement And Utility, Shailaja Somaraju, Richard N. Dalby and
`Michael Pierpont. Pharmaceutical Technology, 21(10) (1997).
`Semi-Automated Spray Pattern Testing Of Nasal Sprays, Shailaja Somaraju, Julie Suman,
`Richard Dalby and Walter Stridick. Pharmaceutical Technology, 21(5), 58-64 (1997).
`Comparison Of A Respiratory Suspension Aerosolized By An Air Jet And Ultrasonic Nebulizer,
`Susan L. Tiano and Richard N. Dalby. Pharmaceutical Development and Technology, 1 (3), 261-
`268 (1996).
`Testing Of Dry Powder Aerosol Formulations In Different Environmental Conditions, Rajkumari N.
`Jashnani, Peter R. Byron and Richard N. Dalby. International Journal of Pharmaceutics, 113,
`123-130 (1994).
`Pitfalls And Opportunities In The Inertial Sizing And Output Testing Of Nebulizers, Richard N.
`Dalby and Susan L. Tiano. Pharmaceutical Technology, 17 (9), 144-156 (1993).
`Preparation, Characterization, And Dissolution Kinetics Of Two Novel Albuterol Salts; Rajkumari
`N. Jashnani, Peter R. Byron and Richard N. Dalby. Journal of Pharmaceutical Science, 82 (6),
`613-616 (1993).
`Validation Of An Improved Rotating Disk Dissolution Apparatus; Rajkumari N. Jashnani, Peter R.
`Byron and Richard N. Dalby. Journal of Pharmaceutical Science, 82 (6), 670-671 (1993).
`Axial Ratio Measurement For Early Detection Of Crystal Growth In Suspension Type Metered
`Dose Inhalers; Elaine M. Phillips, Peter R. Byron and Richard N. Dalby. Pharmaceutical
`Research, 10 (3), 454-456 (1993).
`Droplet Drying And Electrostatic Collection - A Novel Alternative To Conventional Comminution
`Techniques; Richard N. Dalby, Venkatesh Naini and Peter R. Byron. Journal of
`Biopharmaceutical Sciences, 3(1), 91-99 (1992).
`Safety Assessment Of MDIs Containing Flammable Propellants; Richard N. Dalby. Journal of
`Biopharmaceutical Sciences, 3 (1), 49-57 (1992).
`Prediction And Assessment Of Flammability Hazards Associated With Metered Dose Inhalers
`Containing Flammable Propellants; Richard N. Dalby. Pharmaceutical Research, 9 (5), 636-642
`(1992).
`Metered Dose Inhalers Containing Flammable Propellants: -Perspectives And Some Safety
`Evaluation Procedures; Richard N. Dalby and Peter R. Byron. Pharmaceutical Technology, 15
`(10), 54-66 (1991).
`Determination Of Drug Solubility In Aerosol Propellants; Richard N. Dalby, Elaine M. Phillips and
`Peter R. Byron. Pharmaceutical Research, 8(9), 1206-1209 (1991).
`Possible Replacements For CFC-Propelled Metered-Dose Inhalers; Richard N. Dalby. Medical
`Device Technology, 21-25 (1991).
`Special Considerations In The Formulation Of Suspension Type Metered Dose Inhalers; Richard
`N. Dalby. Aerosol Age, 22-89 (1990).
`CFC Propellant Substitution: P-134a As A Potential Replacement For P-12 In MDIs; Richard N.
`Dalby, Peter R. Byron, H.R. Shepherd and Elaine Papadopoulos. Pharmaceutical Technology,
`14,(3), 26-33 (1990).
`Optimized Inhalation Aerosols. I. The Effect Of Spherical Baffle Size And Position Upon The
`Output Of Several Pressurized Nonaqueous Suspension Formulations; Peter R. Byron, Richard
`N. Dalby and Anthony J. Hickey. Pharmaceutical Research, 6 (3), 225-229 (1989).
`
`Page 4 of 24
`
`

`
`Richard Dalby, Ph.D.
`
`
`
`
`
`51.
`
`52.
`
`53.
`
`Effects Of Surfactants On Aerosol Powders In Suspension. Implications For Airborne Particle
`Size; Anthony J. Hickey, Richard N. Dalby and Peter R. Byron. International Journal of
`Pharmaceutics, 4, 267-270 (1988).
`Comparison Of The Output Particle Size Distributions From Pressurized Aerosols Formulated As
`Solutions Or Suspensions, Richard N. Dalby and Peter R. Byron. Pharmaceutical Research, 5
`(1), 36-39, January (1988).
`Effects Of Heat Treatment On The Permeability Of Polyvinylalcohol Films To A Hydrophilic
`Solute; Peter R. Byron and Richard N. Dalby. Journal of Pharmaceutical Sciences, 76 (1), 65-67
`(1987).
`
`2.
`
`3.
`
`4.
`
`5.
`
`
`Miscellaneous (Unreviewed) Papers
`1.
`HSparking Innovation in Drug Delivery. Richard N. Dalby. The Medicine Maker (Accepted,
`November 2015).
`The Respiratory Drug Delivery (RDD®) Conferences. Richard Dalby and Pierre Carlotti.
`Inhalation, 9(5), pages 6-8, October 2015.
`In vitro Bioequivalence Testing of Nasal Sprays H, Diane V. Doughty, Vipra Kundoor, Feiyan Jin,
`Wenchi Hsu and Richard Dalby, Inhalation, 3(1) 22-26, 2009.
`How to Participate in Respiratory Drug Delivery Meetings, Richard N. Dalby, Joanne Peart and
`Peter R. Byron. HInhalationH, October 2007.
`Letter to the Editor. J. Aerosol Med. Concerning “Validity of In Vitro Tests on Aqueous Spray
`Pumps as Surrogates for Nasal Deposition, Absorption and Biologic Response. Julie D. Suman,
`Beth L. Laube and Richard Dalby, J. Aerosol Medicine, 19 (4), 510-521, 2006.
`Meeting Report. The Annual Respiratory Drug Delivery® Symposium, Richard Dalby. Touch
`Briefings, June 2007.
`Meeting Report. Respiratory Drug Delivery Europe 2007. Peter R. Byron, Richard N. Dalby and
`Joanne Peart. Expert Reviews In Respiratory Medicine, 1(1), 2007.
`
`6.
`
`7.
`
`2.
`
`3.
`
`
`3BAbstracts
`1.
`Creating a Comprehensive Exam to Prepare Students for the PCOA. Andrew Coop, Lisa
`Lebovitz, Shannon R. Tucker, George Anagnostou, Christopher Klimas and Richard N. Dalby.
`AACP Annual Meeting, Anaheim, CA, (July 2016).
`Potentially Bioactive or Toxic Metals in E-cigarette Materials of Construction. Sarah L. J. Michel,
`Maureen A. Kane, Abraham Schneider, Thao Vo, Geoffrey Shimberg and Richard N. Dalby. In
`Respiratory Drug Delivery 2016, Richard N. Dalby, Peter R. Byron, Joanne Peart, Julie Suman,
`Paul Young and Daniela Traini, Editors, Book 3, ISBN 1-933722-96-7, p583-586; Davis
`Healthcare International Publishing, River Grove, Illinois (April 2016).
`Plume Geometry Evaluation of Solution-type Metered Dose Inhalers Formulated Using
`Effervescent Aerosol Technology. Mukul S. Kelkar and Richard N. Dalby. In Respiratory Drug
`Delivery 2016, Richard N. Dalby, Peter R. Byron, Joanne Peart, Julie Suman, Paul Young and
`Daniela Traini, Editors, Book 3, ISBN 1-933722-96-7, p579-582; Davis Healthcare International
`Publishing, River Grove, Illinois (April 2016).
`Pharmacy Curriculum Outcomes Assessment (PCOA). Love it or Hate it, It’s Required! Richard
`Dalby, Lisa Lebovitz, Shannon Tucker, Cherokee Layson Wolf, Andrew Coop, Joey Mattingly and
`Nicki Brandt. AACP Annual Meeting, National Harbor, DC (July 2015).
`How PharmD Students Perceive and Reflect on Direct and Sometimes Uncomfortable
`Conversations About Professionalism. Cherokee Layson-Wolf and Richard Dalby. AACP Annual
`Meeting, National Harbor, DC (July 2015).
`Physics for Pre-pharmacy: Is a Spirometer Faster than a Racecar? Alexander Wong, Richard
`Dalby and Kathleen J Pincus. American Association of Physics Teachers (AAPT), College Park,
`Maryland (July 2015).
`Formulation of Suspension-type Pressurized Metered Dose Inhalers Using Effervescent Aerosol
`Technology. Mukul S. Kelkar and Richard N. Dalby. In Respiratory Drug Delivery Europe 2015,
`Richard N. Dalby, Peter R. Byron, Joanne Peart, Julie Suman, Paul Young and Daniela Traini,
`
`4.
`
`5.
`
`6.
`
`7.
`
`
`
`Page 5 of 24
`
`

`
`Richard Dalby, Ph.D.
`
`
`
`
`
`Editors, Book 2, ISBN 1-933722-88-6, p493-496; Davis Healthcare International Publishing, River
`Grove, Illinois (May 2015).
`Formulation of Solution-type Pressurized Metered Dose Inhalers Using Effervescent Aerosol
`Technology. Mukul S. Kelkar and Richard N. Dalby. In Respiratory Drug Delivery Asia 2014,
`Richard N. Dalby, Peter R. Byron, Joanne Peart, Paul Young and Daniela Traini, Editors, Davis
`Healthcare International Publishing, River Grove, Illinois (November 2014).
`Child and Caregiver Reaction to Use of a Prototype Inhalation Monitor as a Training Tool. Mona
`G Tsoukleris, Jill Morgan, Francoise Pradel, Mary E Bollinger, Richard Dalby and Wenchi Hsu.
`Association of Asthma Educators Annual Meeting, San Antonio, TX. August 2014. Accepted as a
`top abstract to be presented from the podium.
`Career Preparation. The Final Frontier: Maintaining Student Attention During Off Campus
`Experiences. Richard Dalby, Shannon Tucker, Lisa Lebovitz and Cherokee Layson Wolf. AACP
`Annual Meeting, Dallas, TX, July 2014.
`Contrasting Approaches and Experiences with Electronic Examinations. Richard Dalby, Veronica
`Shuford, Shannon Tucker and Brigitte Sicat. AACP Annual Meeting, Dallas, TX, July 2014.
`A Simple and Effective Programmatic Assessment Process for Continuous Quality Improvement.
`Lisa Lebovitz and Richard Dalby. AACP Annual Meeting, Dallas, TX, July 2014. Abstract received
`the 2014 AACP Award for Excellence in Assessment.
`Planning an IPE Day, Lebovitz L, Congdon H, Dalby R, Mallott, D and Pecukonis E. All Together
`Better Health, Pittsburgh, PA, June 2014.
`Effervescent Aerosols: A Novel Formulation Technology for Pressurized Metered Dose Inhalers.
`Mukul S. Kelkar and Richard N. Dalby. In Respiratory Drug Delivery 2014, Richard N. Dalby,
`Peter R. Byron, Joanne Peart, Julie Suman, Paul Young and Daniela Traini, Editors, Davis
`Healthcare International Publishing, River Grove, Illinois Vol 3, pp 669-672 (2014). Selected for
`Posters on the Podium presentation.
`Does Trust in the Pharmacist Correlate with Improved Asthma Outcomes, a Pilot Study. Jill
`Morgan, Mona Tsoukleris, Richard Dalby, Wenchi Hsu and Françoise Pradel. The 23rd Pediatric
`Pharmacy Advocacy Group Annual Meeting, Nashville, TN, April 2014.
`Child and Caregiver Reaction to Use of a Prototype Inhalation Monitor as a Training Tool. Mona
`G Tsoukleris, Jill Morgan, Francoise Pradel, Mary E Bollinger, Richard Dalby and Wenchi Hsu.
`ASHP Midyear Meeting, Orlando, FL. December 2013.
`In vitro Delivery Efficiency of Valved Holding Chambers with or without Facemasks. Z Xu, M
`Kelkar, D von Hollen, A Viswanath, K Nikander and R Dalby. Drug Delivery to the Lungs,
`Edinburgh, Scotland, December 2013.
`Novel Approach to an Assessment Committee. Lisa Lebovitz, Fadia T. Shaya and Richard N.
`Dalby. AACP Annual Meeting, Chicago, IL. July 2013.
`Relationship between Student Confidence and Cumulative GPA Upon Completion of Didactic
`PharmD Coursework. Lisa Lebovitz, Stuart T. Haines, Deborah A. Sturpe, David S. Roffman and
`Richard N. Dalby. AACP Annual Meeting, Chicago, IL. July 2013.
`Valved Holding Chambers and Facemask Systems: The Relationship of Facemask Leakage and
`in vitro Drug Delivery Efficiency. Zhen Xu, Wenchi Hsu, Dirk von Hollen, Ashwin Viswanath, Kurt
`Nikander and Richard Dalby. American Association of Pharmaceutical Scientists Annual Meeting,
`Chicago, IL, October 2012.
`Assessment of Facemask Seal Leakage from Six VHC Systems on Two Pediatric Simulated
`Anatomical Models Under Simulated Breathing Conditions. Z. Xu, D. von Hollen, W.Hsu, K.
`Nikander and R. Dalby. European Respiratory Society, Vienna, Austria. September 2012.
`Delivery Efficiency from Valved Holding Chambers with Facemasks: A Comparative Study Using
`Soft Anatomical Face Models. Zhen Xu, Wenchi Hsu, Dirk von Hollen, Ashwin Viswanath, Kurt
`Nikander and Richard N Dalby. In Respiratory Drug Delivery 2012, Richard N. Dalby, Peter R.
`Byron, Joanne Peart, Julie Suman, Stephen Farr and Paul Young, Editors, Davis Healthcare
`International Publishing, Vol 3, pp 809-814 (2012).
`Statistically Significant Improvement in Inhaler Technique Among Patient Volunteers Using an
`Instrumented Inhaler. Wenchi Hsu, Lin Hao, Mona Tsoukleris, Jill Morgan, Mary Bollinger,
`
`Page 6 of 24
`
`8.
`
`9.
`
`10.
`
`11.
`
`12.
`
`13.
`
`14.
`
`15.
`
`16.
`
`17.
`
`18.
`
`19.
`
`20.
`
`21.
`
`22.
`
`23.
`
`
`
`

`
`Richard Dalby, Ph.D.
`
`
`
`
`
`Francoise Pradel & Richard Dalby. American Association of Pharmaceutical Scientists Annual
`Meeting, Washington, DC, October 2011.
`Preliminary Evaluation of an Automated Andersen Cascade Impactor - The “A3G”. Zhen Xu,
`Rajesh Maheshwari, Krishna Maheshwari & Richard Dalby. American Association of
`Pharmaceutical Scientists Annual Meeting, Washington, DC, October 2011.
`Breath by Breath Delivered Dose Comparison from Three Valved Holding Chambers with
`Facemasks Under Simulated Pediatric Breathing Conditions. W. Hsu, D von Hollen, Z. Xu, T Bei,
`K Nikander and R Dalby. European Respiratory Society, Amsterdam, The Netherlands.
`September 2011.
`Does an Integrated Curriculum Lead to Improved Confidence to Practice? Raymond C. Love
`University of Maryland; Lisa Lebovitz, Yunting Fu, and Richard Dalby, University of Maryland
`School of Pharmacy. AACP Annual Meeting. San Antonio, Texas. July 2011.
`Evaluation of Delivery Efficiency from a Valved Holding Chamber with Facemask under
`Simulated Conditions. Wenchi Hsu, Zhen Xu, Dirk von Hollen, Tao Bai, Kurt Nikander and
`Richard Dalby. In Respiratory Drug Delivery Europe 2011, Richard N. Dalby, Peter R. Byron,
`Joanne Peart, Julie Suman and Paul Young, Editors, Davis Healthcare International Publishing,
`May 2011.
`Comparative Analysis of In-use Actuation Parameters with In Vitro Performance of Nasal Spray
`Pumps. Gerallt Williams, Richard N. Dalby and Diane V. Doughty. In Respiratory Drug Delivery
`Europe 2011, Richard N. Dalby, Peter R. Byron, Joanne Peart, Julie Suman and Paul Young,
`Editors, Davis Healthcare International Publishing, May 2011.
`The Effect of Particle Size and Shape on Drug Uptake and Release of Nasal Suspension
`Formulations. Feiyan Jin and Richard N. Dalby. American Association of Pharmaceutical
`Scientists Annual Meeting, New Orleans, LA, November 2010.
`Using an Instrumented Inhaler as a Training Aid to Improve Inhaler Technique Among Patient
`Volunteers. Wenchi Hsu, Mona Tsoukleris, Jill Morgan, Mary E. Bollinger & Richard N. Dalby.
`American Association of Pharmaceutical Scientists Annual Meeting, New Orleans, LA, November
`2010.
`Cross-Course Testing – Concept and Implementation of Coordinated Quizzes at the University of
`Maryland School of Pharmacy. Lisa Lebovitz, Douglas A. Nutter, Yunting Fu, David S. Roffman &
`Richard Dalby. AACP Annual Meeting, Seattle, WA, July 2010.
`In Vitro Beclomethasone Dipropionate Dissolution and Uptake Rates From Nasal Suspensions
`Comprised of Differing Primary Drug Particle Sizes. Feiyan Jin and Richard Dalby. Richard N.
`Dalby, Diane Doughty and Vipra Kundoor. In Respiratory Drug Delivery 2010, Orlando, FL.
`Richard N. Dalby, Peter R. Byron, Joanne Peart, Julie Suman and Paul Young, Editors, Davis
`Healthcare International Publishing, April 2010.
`Realistic Evaluation of a Valved Holding Chamber with Facemask - Using a Soft Anatomical
`Model Face to Evaluate Aerosol Output Under Simulated Use Conditions. Wenchi Hsu, Tao Bai,
`Dirk von Hollen, Kurt Nikander and Richard Dalby. In Respiratory Drug Delivery 2010, Orlando,
`FL. Richard N. Dalby, Peter R. Byron, Joanne Peart, Julie Suman and Paul Young, Editors, Davis
`Healthcare International Publishing, April 2010.
`Validation of a Method to Visualize the Effect of Cascade Impactor Operating Temperature on
`Stage Deposition. Wenchi Hsu, Vipra Kundoor and Richard N. Dalby. American Association of
`Pharmaceutical Scientists Annual Meeting, Los Angeles, CA. November 2009.
`Influence of Adult and Pediatric Hand-Related Variability on in vitro Performance of Flonase®
`Nasal Spray. D. V. Doughty, C. Vibbert, M. E. Bollinger, A. Kewalramani and R. N. Dalby.
`American Association of Pharmaceutical Scientists Annual Meeting, Los Angeles, CA. November
`2009.
`In Vitro Uptake of Nasal Sprays Containing Suspension Formulations in Calu-3 Human Airway
`Cells. Feiyan Jin and Richard N. Dalby. American Association of Pharmaceutical Scientists
`Annual Meeting, Los Angeles, CA. November 2009.
`Visualization of Facial and Ocular Deposition Using a Color Based Technique. Vipra Kundoor and
`Richard Dalby. American Association of Pharmaceutical Scientists Annual Meeting, Los Angeles,
`CA. November 2009.
`
`Page 7 of 24
`
`24.
`
`25.
`
`26.
`
`27.
`
`28.
`
`29.
`
`30.
`
`31.
`
`32.
`
`33.
`
`34.
`
`35.
`
`36.
`
`37.
`
`
`
`

`
`Richard Dalby, Ph.D.
`
`
`
`
`
`38.
`
`39.
`
`40.
`
`41.
`
`42.
`
`43.
`
`44.
`
`45.
`
`46.
`
`47.
`
`48.
`
`49.
`
`50.
`
`51.
`
`52.
`
`53.
`
`
`
`Visualizing the Effect of Cascade Impactor Operating Temperature on the Size and Evaporation
`Rate of Nebulized Droplets. Wenchi Hsu, Vipra Kundoor and Richard N. Dalby. In Respiratory
`Drug Delivery Europe 2009, Richard N. Dalby, Peter R. Byron, Joanne Peart, Julie Suman and
`Paul Young, Editors, Davis Healthcare International Publishing, May 2009.
`In vitro and in vivo Terameprocol efficacy studies in HPV infection models. Christensen N, Dalby
`R, Khanna N. The 25th International Papillomavirus Conference, Malmö, Sweden, May 2009.
`Uptake and local metabolism of beclomethasone dipropionate in Calu-3 human airway cells.
`Feiyan Jin and Richard N. Dalby. American Association of Pharmaceutical Scientists Annual
`Meeting, Atlanta, GA. November 2008.
`Comparison of Deposition Patterns of Nasal Nebulizers and Aqueous Nasal Spray Pumps Using
`a Colorimetric Technique. Vipra Kundoor and Richard Dalby. American Association of
`Pharmaceutical Scientists Annual Meeting, Atlanta, GA. November 2008.
`Determination of Patient-Relevant Settings for In Vitro Evaluation of Flonase Using Automated
`Actuation Stations. Diane Doughty and Richard Dalby. American Association of Pharmaceutical
`Scientists Annual Meeting, Atlanta, GA. November 2008.
`The accuracy of Ventolin® dose counters using a force-instrumented pressurized metered dose
`inhaler under simulated use conditions. Wenchi Hsu and Richard Dalby. American Association of
`Pharmaceutical Scientists Annual Meeting, Atlanta, GA. November 2008.
`Assessment of Nasal Spray Deposition in a Nose Model Using a Colorimetric Technique –
`Influence of Formulation and Airflows, Vipra Kundoor and Richard N. Dalby. In Respiratory Drug
`Delivery 2008, Richard N. Dalby, Peter R. Byron, Joanne Peart, Julie Suman and Paul Young,
`Editors, Davis Healthcare International Publishing, May 2008.
`Assessment of Nasal Spray Deposition in a Nose Model Using Colorimetric Techniques. Vipra
`Kundoor and Richard N. Dalby. American Association of Pharmaceutical Scientists Annual
`Meeting, San Diego, CA. November 2007.
`The Effect of Volunteer Study-derived Actuation Parameters on Sprayed Droplet Size.
`Wenchi Hsu, Diane V. Doughty and Richard N. Dalby. American Association of Pharmaceutical
`Scientists Annual Meeting, San Diego, CA. November 2007.
`Handedness and Gender Effects on the Derivation of Machine Actuation Parameters for Nasal
`Sprays. Diane Doughty and Richard N. Dalby. American Association of Pharmaceutical
`Scientists Annual Meeting, San Diego, CA. November 2007.
`Preliminary Study on the Bioequivalence in Nasal Sprays Containing Suspension Formulations.
`Feiyan Jin and Richard N. Dalby. American Association of Pharmaceutical Scientists Annual
`Meeting, San Diego, CA. November 2007.
`Influence of Shaking on the Spray Weight of Nasal Spray Pumps; Lei Diao and Richard N. Dalby.
`American Association of Pharmaceutical Scientists Annual Meeting, San Diego, CA. November
`2007.
`Characterization of Delivered Dose and Droplet Size Distribution of Flovent HFA Utilizing the Next
`Generation Impactor (NGI) and Breath Simulation with OptiHaler. Tao Bai and Richard N. Dalby,
`American Association of Pharmaceutical Scientists Annual Meeting, San Diego, CA. November
`2007.
`Phospholipid Induced In-Vivo Particle Migration To Enhance Pulmonary Deposition. Sudipta
`Ganguly, Vikas Moolchandani, Joseph Roche, Paul S. Shapiro, Shailaja Somaraju, Natalie
`Eddington and Richard N. Dalby. American Association of Pharmaceutical Scientists Annual
`Meeting, San Diego, CA. November 2007.
`Determination of Automated Nasal Actuator Parameters Based on a Twenty Volunteer Study.
`Diane V. Doughty and Richard N. Dalby. In Respiratory Drug Delivery Europe 2007, Richard N.
`Dalby, Peter R. Byron, Joanne Peart and Julie Suman, Editors, Davis Healthcare International
`Publishing, April 2007.
`Modification of Nasal Spray Dip Tubes to Decrease Formulation Waste and Improve Content
`Uniformity by Decreasing the Number of Sprays in the Tail-Off Period. Diane Doughty and
`Richard N. Dalby. Parenteral Drug Association National Meeting, Las Vegas, NV. March 2007.
`
`Page 8 of 24
`
`

`
`Richard Dalby, Ph.D.
`
`
`
`
`
`54.
`
`55.
`
`56.
`
`57.
`
`58.
`
`59.
`
`60.
`
`61.
`
`62.
`
`63.
`
`64.
`
`65.
`
`66.
`
`67.
`
`68.
`
`69.
`
`
`
`A Novel Way to Increase the Efficiency of Nasal Spray Pumps. Diane Doughty and Richard N.
`Dalby. American Association of Pharmaceutical Scientists Annual Meeting, San Antonio, TX.
`October 2006.
`The Influence of Tilt Angles on the Efficiencies of Jet Nebulizers. Feiyan Jin and Richard N.
`Dalby. American Association of Pharmaceutical Scientists Annual Meeting, San Antonio, TX.
`October 2006.
`A Phospholipid-Based Inhalation System: Formulation And Characterization Of Particle Migration
`On Lung Epithelial Cell Surfaces. Sudipta Ganguly, Paul S. Shapiro, Shailaja Somaraju and
`Richard N. Dalby. American Association of Pharmaceutical Scientists Ann